Whole Genome Amplification Market is estimated at around US$ 5.08 Billion by the end of 2031
The global Whole Genome Amplification Market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a re…
The global Whole Genome Amplification Market is estimated at around US$ 5.08 Bn by the end of 2031, as indicated by a re…
A US-based team of researchers has recently developed a microfluidic device for isolating a genomic DNA, which is to be…
Die SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) gab heute Veränderungen in Management und Aufsichtsr…
SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced changes to the management team and super…
. - Revenue increased 3-fold to €1.8 million - Growth momentum sets stage for strong 2017 business outlook - Operatin…
. - Verdreifachung der Umsätze auf 1,8 Mio. Euro Operativer Cashflow um 16% verbessert; Break-even in 2017 erwartet -…
SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the successful completion of a second co…
Die SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) hat heute den erfolgreichen Abschluss eines zweiten…
Integration in weniger als drei Monaten abgeschlossen SYGNIS- und C.B.S.-Standorte in San Diego zusammengeführt Vertrie…
SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the successful completion of the integra…